683 CAPITAL MANAGEMENT LLC
Q4 2021 Form 13-F
NEW YORK, NEW YORK
CIK 0001404574
· CRD 156181
· SEC-registered investment adviser
Consolidated report · includes
1 manager
since Q2 2013
$2.7B Reported Value Total
683 CAPITAL MANAGEMENT, LLC reports 3 total accounts under management (AUM). There are 3 discretionary accounts valued at $2,895,277,679, and 0 non-discretionary accounts.
Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
SEC Registered
Discretionary Manager
Private funds (Form ADV)
2 funds
· $2.4B gross asset value
Hedge Fund: $2.4B
Source: Form ADV filed 2026-03-30
Reported value
$2.7B
Quarter over quarter
-5.9%
Holdings
327
Top-10 concentration
45.0%
Filing Structure
Reports holdings for
- 683 Capital Partners LP · File #028-14774 · since Q2 2013
Key People
Form ADV owners & control persons
John Andrew Levin
MANAGING MEMBER
Ari Jonathan Zweiman
MANAGING MEMBER
Joseph S Patt
PARTNER
Filing Navigation
Coverage begins with the second quarter of 2013. Earlier quarters are not shown while their accuracy is being verified.
13F Metrics
Loading 13F Metrics
Q4 2021 13F record
Q4 2021 13F filing summary
| Period of report | December 31, 2021 |
|---|---|
| Filed | February 14, 2022 |
| Form | 13F-HR |
| Reported value | $2.7B |
| Positions | 327 |
| Change in reported value | +6.0% |
| New positions | 175 |
| Exited positions | 46 |
| Position turnover | 59.3% |
| Top-10 concentration | 45.0% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q2 2026 13F
Filed Aug 14, 2026
|
125 | $2.0B |
|
Q1 2026 13F
Filed May 15, 2026
|
204 | $1.9B |
|
Q4 2025 13F
Filed Feb 17, 2026
|
201 | $2.3B |
|
Q3 2025 13F
Filed Nov 14, 2025
|
113 | $1.9B |
|
Q2 2025 13F
Filed Aug 14, 2025
|
111 | $1.5B |
|
Q1 2025 13F
Filed May 15, 2025
|
114 | $1.4B |
|
Q4 2024 13F
Filed Feb 14, 2025
|
205 | $1.6B |
|
Q3 2024 13F
Filed Nov 14, 2024
|
124 | $1.3B |
|
Q2 2024 13F
Filed Aug 14, 2024
|
124 | $1.3B |
|
Q1 2024 13F
Filed May 15, 2024
|
118 | $1.4B |
|
Q4 2023 13F
Filed Feb 14, 2024
|
236 | $1.2B |
|
Q3 2023 13F
Filed Nov 14, 2023
|
127 | $1.3B |
|
Q2 2023 13F
Filed Aug 14, 2023
|
135 | $1.4B |
|
Q1 2023 13F
Filed May 15, 2023
|
263 | $1.3B |
|
Q4 2022 13F
Filed Feb 14, 2023
|
290 | $1.2B |
|
Q3 2022 13F
Filed Nov 14, 2022
|
231 | $1.3B |
|
Q2 2022 13F
Filed Aug 15, 2022
|
260 | $1.4B |
|
Q1 2022 13F
Filed May 16, 2022
|
342 | $1.9B |
|
Q4 2021 13F
Filed Feb 14, 2022
|
327 | $2.7B |
|
Q3 2021 13F
Filed Nov 15, 2021
|
199 | $2.6B |
33 earlier quarters on file — choose one from the quarter menu above.
Top 20 holdings · Q4 2021
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | GM C GENERAL MTRS CO | $206.4M | 7.59% |
| 2 | AMC P AMC ENTMT HLDGS INC | $182.5M | 6.72% |
| 3 | CVNA CARVANA CO | $139.1M | 5.12% |
| 4 | ENVA ENOVA INTL INC | $124.9M | 4.59% |
| 5 | OPEN OPENDOOR TECHNOLOGIES INC | $106.8M | 3.93% |
| 6 | HLF HERBALIFE NUTRITION LTD | $103.6M | 3.81% |
| 7 | CDLX CARDLYTICS INC | $100.1M | 3.68% |
| 8 | IAC IAC INTERACTIVECORP NEW | $99.3M | 3.65% |
| 9 | FE FIRSTENERGY CORP | $94.5M | 3.48% |
| 10 | AMC C AMC ENTMT HLDGS INC | $65.2M | 2.4% |
| 11 | LKFT GALAPAGOS NV | $49.9M | 1.84% |
| 12 | UCO P PROSHARES TR II | $39.1M | 1.44% |
| 13 | MMP MAGELLAN MIDSTREAM PRTNRS LP | $38.7M | 1.43% |
| 14 | AFMD AFFIMED N V | $32.6M | 1.2% |
| 15 | MGTX MEIRAGTX HLDGS PLC | $32.2M | 1.18% |
| 16 | DDS P DILLARDS INC | $30.6M | 1.12% |
| 17 | SNDX SYNDAX PHARMACEUTICALS INC | $30.5M | 1.12% |
| 18 | ADNT ADIENT PLC | $30.4M | 1.12% |
| 19 | TWND TAILWIND ACQUISITION CORP | $29.5M | 1.09% |
| 20 | ATRA ATARA BIOTHERAPEUTICS INC | $28.1M | 1.03% |
Values as reported on the Q4 2021 Form 13F. Every position is in the holdings table below.